MYELOID LEUKEMIA
Clinical trials for MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for leukemia patients Who've run out of options
Disease control Recruiting nowThis study tests an experimental pill called HQP1351 in adults with chronic myeloid leukemia (CML) or a related blood cancer (Ph+ ALL) that has stopped responding to at least two standard treatments. The goal is to find the best dose and check how safe and effective the drug is. …
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 26, 2026 07:21 UTC
-
New hope for hard-to-treat leukemia: drug combo targets resistant cancer cells
Disease control Recruiting nowThis study tests a new combination of drugs for people with acute myeloid leukemia (AML) whose cancer did not respond to or came back after standard treatment. About 30 adults will receive mitoxantrone along with venetoclax and azacitidine to see if this mix can shrink the cancer…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New combo therapy aims to rebuild strength in young cancer survivors after transplant
Disease control Recruiting nowThis study tests whether a tailored exercise program combined with a vitamin-like supplement (NAD+ precursor) can improve muscle mass, strength, and fitness in teens and young adults who had a bone marrow transplant for leukemia or other blood disorders. Participants will be rand…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New drug combo targets Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a combination of two drugs, gilteritinib and momelotinib, for adults with a specific type of acute myeloid leukemia (AML) that has come back or not responded to treatment. The main goal is to find the safest dose of momelotinib when given with gilteritinib. About…
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Exercise may turn back the clock for blood cancer survivors
Knowledge-focused Recruiting nowThis study looks at whether a tailored exercise program can slow down the aging process in people aged 50 and older who have survived blood cancers like leukemia or lymphoma. Researchers want to find out how much and what type of exercise is needed to make a difference. The goal …
Matched conditions: MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated May 26, 2026 07:34 UTC